Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.41 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3924286 | 1.00 | AOC3 (0.53) | AOC3LMNASMN1; SMN2TSHRMAPK1 | |
| SCHEMBL3924289 | 1.00 | AOC3 (0.53) | AOC3LMNASMN1; SMN2TSHRMAPK1 | |
| SCHEMBL29700206 | 0.82 | AOC3 (0.55) | AOC3LMNASMN1; SMN2TSHRMAPK1 | |
| SCHEMBL10799093 | 0.82 | TAAR1 (0.39) | AOC3LMNASMN1; SMN2TSHRHIF1A | |
| SCHEMBL3917589 | 0.81 | AOC3 (0.50) | AOC3LMNASMN1; SMN2TSHRMAPK1 | |
| SCHEMBL3917591 | 0.81 | AOC3 (0.50) | AOC3LMNASMN1; SMN2TSHRMAPK1 | |
| SCHEMBL27504475 | 0.80 | TAAR1 (0.60) | LMNASMN1; SMN2TSHRHIF1ATDP1 | |
| SCHEMBL6715483 | 0.80 | TAAR1 (0.60) | LMNASMN1; SMN2TSHRHIF1ATDP1 | |
| SCHEMBL1155443 | 0.80 | AOC3 (0.53) | AOC3LMNASMN1; SMN2TSHRMAPK1 | |
| SCHEMBL4297797 | 0.80 | AOC3 (0.53) | AOC3LMNASMN1; SMN2TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110016444-B | Acinetobacter ZJPH1806 and application thereof in preparation of miconazole chiral intermediate | 浙江工业大学 | 2021-05-11 | — | — | CN | claimed |
| EP-0718407-B1 | Intermediates for the synthesis of eliprodil enantiomers and process for their preparation | SANOFI SYNTHELABO (FR) | 2002-02-13 | — | — | EP | claimed |
| US-5677168-A | Enantiomeric separation of (RS)1-(4-chlorophenyl)-2-chloroethanol by lipase catalyzed hydrolysis of its acetate | SYNTHELABO (FR) | 1997-10-14 | — | — | US | claimed |
| EP-0718407-A1 | Intermediates for the synthesis of eliprodil enantiomers and process for their preparation | SYNTHELABO (FR) | 1996-06-26 | — | — | EP | claimed |
| CN-119614529-A | Short-chain dehydrogenase, engineering bacteria and application thereof in asymmetric reduction of potential chiral carbonyl compounds | 杭州文德阶生物科技有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-110016444-B | Acinetobacter ZJPH1806 and application thereof in preparation of miconazole chiral intermediate | 浙江工业大学 | 2021-05-11 | — | — | CN | disclosed |
| CN-110016444-B | Acinetobacter ZJPH1806 and application thereof in preparation of miconazole chiral intermediate | 浙江工业大学 | 2021-05-11 | — | — | CN | disclosed |
| EP-1741693-B1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOLS | NAGOYA IND SCIENCE RES INST (JP) | 2011-08-03 | — | — | EP | disclosed |
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | NAGOYA INDUSTRIAL SCIENCE RESEARCH CENTER (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1741693-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALCOHOLS | Nagoya Industrial Science Research Institute (JP) | 2007-01-10 | — | — | EP | disclosed |
| CN-1668753-A | Coupled enzymatic reaction system using a formate dehydrogenase derived from candida boidinii | DEGUSSA (DE) | 2005-09-14 | — | — | CN | disclosed |
| CN-1668738-A | Two-phase coupled enzymatic reaction system based on alcohol dehydrogenase | DEGUSSA (DE) | 2005-09-14 | — | — | CN | disclosed |
| EP-0718407-B1 | Intermediates for the synthesis of eliprodil enantiomers and process for their preparation | SANOFI SYNTHELABO (FR) | 2002-02-13 | — | — | EP | disclosed |
| US-5677168-A | Enantiomeric separation of (RS)1-(4-chlorophenyl)-2-chloroethanol by lipase catalyzed hydrolysis of its acetate | SYNTHELABO (FR) | 1997-10-14 | — | — | US | disclosed |
| US-5677168-A | Enantiomeric separation of (RS)1-(4-chlorophenyl)-2-chloroethanol by lipase catalyzed hydrolysis of its acetate | SYNTHELABO (FR) | 1997-10-14 | — | — | US | disclosed |
| EP-0718407-A1 | Intermediates for the synthesis of eliprodil enantiomers and process for their preparation | SYNTHELABO (FR) | 1996-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225528-A1 | Process for Producing Optically Active Alcohol | ADH1C, ADH1A, ADH5 | AOC3 2253/4885LMNA 3010/4885SMN1; SMN2 4638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.